Pathology Case Studies (4 weeks)
Title of Clerkship: Pathology Case Studies (4 weeks)
Elective Year(s): Fourth-Year Elective
Department: Pathology
Type of Elective: Non-clinical
Clerkship Site: UTMC, Dowling Hall
Course Number: PATH 713
Blocks Available: All
Number of Students/Block: 20
Faculty: Dr. Amira Gohara
Elective Description/Requirements: Students meet daily; three clinical cases are presented by students; all students participate in discussion of cases as well as related learning issues. Each clerk must present at least 4 cases per 4-week rotation.
Length of Clerkship: 4 weeks
Links to Core Competencies/Educational Course Objectives: At the end of this elective, the student will be able to:
- Apply the principles of basic sciences to the etiology, pathophysiology, diagnostic testing, prevention, and treatment of human diseases. (EPOs: MK-4)
- Apply biomedical knowledge to clinical problems and interpret laboratory data imaging studies and other diagnostic test and procedures to deliver safe and efficient clinical care (EPOs: PC-6)
- Prepare and deliver a focused presentation of a clinical case (EPOs: IPC-2, SBP-5)
- Discuss the pre analytic variables that affect lab results (EPOs: MK-1, PC-6)
- Explain the current and future role of Molecular diagnostic testing (EPOs: MK-7)
Professionalism: UT/COM students will meet or exceed the institutional standards for professionalism as stated in the current Educational Program Objectives and the current Educational Course Objectives for the Sponsoring Department.
Instructional Methods:
- Case studies
- Small group
- Clinical skills
- Diagnostic tests – use/interpretation
- Interpretation of lab data
- Problem-solving exercise
Evaluation Methods:
- Attendance
- Case presentation
- Formative problem-solving exercises
- Professionalism assessment
Prerequisites: Successful Completion of preclerkship curriculum
Clerkship Director: Amira Gohara, MD
Clerkship Coordinator: Mary Okdie
Phone Number: 419.383.3477
Email: Mary.Hurley@utoledo.edu
Special Requirements: None
ECC Approved
December 2024